Back to School: How biopharma can reboot drug development. Access exclusive analysis here

0828 JLABS Blue Knight
BioCentury & Getty Images

Deals

BARDA enlisting start-ups in fight against COVID-19 via JLABS collaboration

JLABS funneling start-up innovation to BARDA via Blue Knight initiative

JLABS is providing BARDA access to start-up innovation the government agency can fast track to fight COVID-19 and future health threats.

Aug 28, 2020 | 11:25 PM GMT

A collaboration between JLABS and BARDA gives the government agency access to start-ups that it needs to fast track new, innovative COVID-19 therapies and diagnostics it otherwise would struggle to find.

The Johnson & Johnson (NYSE:JNJ) incubator and the Biomedical Advanced Research and Development Authority (BARDA) launched the Blue Knight collaboration in April

Read the full 1022 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE